Am I a Good Candidate for a Liver Transplant? A Hepatologist Explains Who Needs One — and Who Doesn’t
Patients ask me two opposite questions in the same week: “Doctor, am I sick enough to need a transplant?” and “Doctor, am I too sick for one?” Both are the right question, because a liver transplant is a timing decision, not a last resort or a default treatment for every damaged liver. In my practice, I evaluate a patient when living with the diseased liver has become more dangerous than the surgery itself — that single principle drives every test, score, and conversation below. One correction I make early with almost every patient: most of what you’ll read online about transplant eligibility is written for the American deceased-donor system. In India, roughly 8 in 10 liver transplants are living donor (LDLT) — a family member gives part of their liver. That changes the eligibility conversation substantially. It isn’t “how sick do you have to be to move up a waiting list” — it’s “is transplant the right call, and do you have a donor.” I’ll flag where this distinction matters throughout. Does Everyone With Cirrhosis Need a Transplant? No. Cirrhosis has two clinically distinct phases, and only one puts transplant on the table. Compensated cirrhosis — the liver is scarred but still functioning. Patients are often working, asymptomatic, with no fluid buildup or confusion. This group needs monitoring, not transplant evaluation. Decompensated cirrhosis — the liver has stopped keeping up. This is the group I actually start evaluating: Recurrent ascites (fluid buildup) Spontaneous bacterial peritonitis Jaundice Hepatic encephalopathy (confusion) Variceal bleeding Worsening kidney function Sarcopenia (muscle wasting) Repeated hospital admissions for any of the above If you’ve already been evaluated and told no, see what actually disqualifies you from a transplant. Case — early referral changed the outcome. A 55-year-old male presented with acute-on-chronic liver failure, deteriorating rapidly — the kind of presentation where the decision window can be as tight as 2 to 3 days. His wife came forward as donor; she wasn’t a blood-group match, so the transplant proceeded as ABO-incompatible, within a selected-cohort protocol where survival outcomes run 80–85% in appropriately selected, desensitized cases. Early recognition and early transplant, not last-minute rescue, was what made survival possible. What Actually Causes the Liver Disease That Leads Here MASLD (formerly NAFLD/fatty liver) — the fastest-growing indication in India right now Alcohol-related liver disease Chronic hepatitis B and C Autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis Wilson disease, hemochromatosis, alpha-1 antitrypsin deficiency Acute liver failure (days-long deterioration in a previously healthy liver — this one moves fast) Selected hepatocellular carcinoma (HCC) How I Actually Decide — Beyond the Lab Numbers This is the part that separates a real evaluation from a checklist. Disease severity numbers matter — bilirubin, INR, creatinine, sodium, albumin, platelets, imaging. But how MELD gets used changes entirely depending on whether we’re considering DDLT or LDLT, and this is where most patient-facing content gets it backwards. DDLT (Deceased Donor) LDLT (Living Donor) Role of MELD score Drives allocation — “sickest first” on a waitlist Measures surgical risk, not queue position Ideal patient state Higher MELD moves you up the list Moderate/lower MELD often tolerates surgery better Waiting Determined by organ availability Planned around donor readiness Risk of waiting too long Patient may not survive to allocation Patient may become too sick to safely undergo LDLT India relevance ~20% of transplants ~80% of transplants Wait too long for MELD to climb, and an LDLT candidate can become too sick to safely survive the surgery — the opposite of how DDLT logic works. This is exactly why early evaluation, long before a patient is critically ill, matters more in India’s LDLT-majority reality than it does in a pure allocation-queue system. On cancer eligibility specifically: I don’t work off a rigid checklist like Milan criteria alone. Tumor size and number are a starting point, not the whole picture — vascular invasion, response to bridging therapy, and overall liver reserve all factor into whether transplant is the right call for a given patient. Physical fitness for major surgery — heart, lung, kidney function, nutritional status, frailty, infection status all get assessed. Psychological and family readiness — lifelong medication adherence isn’t optional after transplant, and I look for whether a patient and their support system understand that before, not after, listing. Case — delayed referral, severe alcoholic hepatitis. One of the most heartbreaking patterns I see: patients with severe alcoholic hepatitis reaching a tertiary center only after multi-organ failure has already set in. By the time they arrive in the ICU, the critical window for intervention has closed — infection often rules out standard therapy, and an unstable patient can’t safely undergo transplant evaluation. This pattern disproportionately hits patients in their 30s and 40s with young families. Severe alcoholic hepatitis is a medical emergency, not a wait-and-watch diagnosis — early referral to a specialized liver unit is the decisive factor between a second chance and a preventable outcome. When You Do NOT Need a Transplant Compensated, stable cirrhosis Reversible liver injury Early fibrosis Successfully treated hepatitis MASLD without decompensation Case — recovered without transplant. A young male came in with a first episode of severe alcoholic hepatitis — Maddrey discriminant function above 80, a picture that looked transplant-bound. A sepsis screen was negative. With steroid therapy and aggressive nutritional support, he recovered fully without transplantation. Evaluation isn’t a pipeline toward surgery. Sometimes the right call is intensive medical management, and a first-episode presentation with good support behind it is exactly where that call gets made. When Transplant Isn’t Possible Yet (Not Never) Active uncontrolled infection Ongoing alcohol or substance use Severe uncontrolled cardiac disease Malignancy outside transplant criteria Not currently fit for major surgery Most of these are reversible with treatment first — this is a “not now,” not a permanent door closing, and I make a point of telling patients that distinction explicitly. Living Donor vs. Deceased Donor — The Part Most Articles Underweight In India, this is usually the real fork in the road, not MELD-based queue position.


